ALAM JOHN J 4

What Happened
John J. Alam, listed as a 10% owner of CervoMed (CRVO), reported on Form 4 that 8,150 derivative shares were acquired on June 8, 2026 at $0.00. The award is an option to purchase common stock (no immediate cash paid) granted to his spouse, Sylvie Gregoire, PharmD., who is a non-employee director of the company. This is an award/grant (not an open-market purchase or sale).

Key Details

• Transaction date: 2026-06-08; Form 4 filed: 2026-06-10 (timely filing).
• Transaction type: Award/Grant (code A); price per share reported: $0.00; total reported cash value: $0.
• Shares reported: 8,150 underlying shares/options granted.
• Shares owned after transaction: Not specified in this filing.
• Footnote: The option was granted to Sylvie Gregoire (the reporting person’s spouse). Mr. Alam disclaims beneficial ownership of these securities; this report does not admit he beneficially owns them.
• Vesting: The underlying shares vest in equal monthly 1/12th increments on the last day of each month beginning June 30, 2026, subject to Dr. Gregoire’s continued service.

Context
This is a derivative award (option grant) to a non-employee director (who is also the spouse of the 10% owner). Because the award vests over time and was not sold immediately, it does not indicate an immediate buy/sell decision in the market. The reporting person disclaims beneficial ownership, so retail investors should treat this as a director compensation grant rather than a direct insider purchase signal by Mr. Alam.